CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for DionyMed Brands Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

DionyMed Brands Inc
2200, 885 West Georgia Street
Phone: (416) 209-5982p:416 209-5982 VANCOUVER, BC  V6C 2G2  Canada Ticker: DYMEDYME
Placed under Receivership on 10/29/2019
On 10/23/2019, DionyMed Brands Inc. announced that pursuant to GLAS USA LLC and GLAS America LLC's Notice of Intention to Enforce Security under section 244 of the Bankruptcy and Insolvency Act (Canada), the two Companies have filed a Petition for the Appointment of a Receiver over DionyMed Brands Inc. with the Supreme Court of British Columbia.
On 10/29/2019, the Supreme Court of British Columbia appointed FTI Consulting Canada Inc. as Receiver of the assets, undertakings and properties of DionyMed Brands Inc. DionyMed's four directors, Susan Watt, David Kerr, Brett Moyer and Stephen Dineley, resigned effective upon granting of the Receivership Order.
On 10/30/2019, DionyMed received notice that it no longer qualifies for the OTCQB market.
Business Summary
Dionymed Brands Inc is a Canada-based company engaged in cannabis business sector. The Company, through its subsidiaries, operates a distribution, manufacturing services and online retail platform for cannabis cultivators, distributors and processors with current operations in California and Oregon. It is focused on the sale of branded products online and through retail dispensaries; manufacturing and processing branded cannabis products for delivery direct to consumers and to retail dispensaries; and wholesale distribution and logistics management on behalf of cultivators, manufacturers and third party brands.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 IRA CQ
Score		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating		 Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201912/31/2018Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director ScottAckerman 12/30/2016 12/30/2016
Chief Operating Officer HentieHoffmann 1/18/2010 1/18/2010
Director BrentAckerman 12/30/2016 12/30/2016
Director DougMcFaul 12/30/2016 12/30/2016

Subsidiaries
Business Name Address City State/Province Country
HomeTown Heart 414 Lesser Street Oakland CA United States

Business Names
Business Name
Chrysalis Capital IV Corporation
DYME
HEG.H
Homeland Energy Group Ltd.
HOMETOWN HEART
SNX.H

General Information
Number of Employees: 32 (As of 12/31/2012)
Outstanding Shares: 31,203,162 (As of 7/4/2019)
Stock Exchange: CNQ
Fax Number: (416) 209-5982


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 10, 2019